Clinical trial
Study to Evaluate the Effect of Renal Function on the Single-Dose…
NCT00119639 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00119639 |
|---|---|
| Title | Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of BAY 43-9006 |
| Official title | A Study to Evaluate the Effect of Renal Function on the Single-Dose Pharmacokinetics of Sorafenib (BAY 43-9006, Nexavar). |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Diseases |
| Intervention type | Drug |
| Interventions | Sorafenib (BAY43-9006, Nexavar) |
| Enrollment | 32 |
| Start date | Jun 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Jul 14, 2005 |
| Last update posted | Jan 16, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: